IN2012DN05163A - - Google Patents

Download PDF

Info

Publication number
IN2012DN05163A
IN2012DN05163A IN5163DEN2012A IN2012DN05163A IN 2012DN05163 A IN2012DN05163 A IN 2012DN05163A IN 5163DEN2012 A IN5163DEN2012 A IN 5163DEN2012A IN 2012DN05163 A IN2012DN05163 A IN 2012DN05163A
Authority
IN
India
Prior art keywords
vaccine
composition
endosialin
edb
tenascin
Prior art date
Application number
Other languages
English (en)
Inventor
Anna-Karin Olsson
Lars Hellman
Original Assignee
Theravac Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravac Pharmaceuticals Ab filed Critical Theravac Pharmaceuticals Ab
Publication of IN2012DN05163A publication Critical patent/IN2012DN05163A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN5163DEN2012 2009-12-15 2010-12-15 IN2012DN05163A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0901565A SE535982C2 (sv) 2009-12-15 2009-12-15 Ett nytt vaccin som angriper tumörkärl som ett effektivt redskap i tumörterapi
PCT/SE2010/000300 WO2011075035A1 (en) 2009-12-15 2010-12-15 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy

Publications (1)

Publication Number Publication Date
IN2012DN05163A true IN2012DN05163A (de) 2015-10-23

Family

ID=44167552

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5163DEN2012 IN2012DN05163A (de) 2009-12-15 2010-12-15

Country Status (10)

Country Link
US (1) US20130122028A1 (de)
EP (1) EP2512510A4 (de)
JP (1) JP2013513659A (de)
CN (1) CN102791290A (de)
AU (1) AU2010332327A1 (de)
CA (1) CA2783969A1 (de)
IN (1) IN2012DN05163A (de)
RU (1) RU2012124261A (de)
SE (1) SE535982C2 (de)
WO (1) WO2011075035A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104277102B (zh) * 2014-06-27 2017-04-12 李光辉 一种检测乳腺癌标志物Annexin A1抗原表位氨基酸序列及应用
CN107903307B (zh) * 2017-10-17 2020-12-18 北京大学 一种高亲和力edb-fn蛋白靶向肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017604A1 (en) * 1991-03-26 1992-10-15 Otsuka Pharmaceutical Factory, Inc. Anti-eda monoclonal antibody
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
EP1752160A3 (de) * 2001-04-06 2007-05-30 Mannkind Corporation Epitop-Sequenzen
JP4869603B2 (ja) * 2002-11-20 2012-02-08 キャンサー・リサーチ・テクノロジー・リミテッド 抗体、ポリペプチドおよびその使用
TWI445525B (zh) * 2004-06-02 2014-07-21 Sidney Kimmel Cancer Ct 用以偵測、成像和治療瘤新生或血管新生的血管標的物之用途
AU2005321898B2 (en) * 2004-12-29 2012-07-19 Mannkind Corporation Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
GB0508726D0 (en) * 2005-04-29 2005-06-08 Bioinvent Int Ab Polypeptide, vaccine and use thereof
US20060286074A1 (en) * 2005-05-31 2006-12-21 Yucheng Tang Methods for immunotherapy of cancer
ES2291071B1 (es) * 2005-06-13 2009-03-16 Proyecto De Biomedicina Cima, S.L. Agentes y metodos basados en el uso del dominio eda de la fibronectina.
ZA200803759B (en) * 2005-11-02 2009-10-28 Univ Duke Concurrent chemotherapy and immunotherapy
ES2536465T3 (es) * 2008-10-01 2015-05-25 Immatics Biotechnologies Gmbh Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres

Also Published As

Publication number Publication date
SE535982C2 (sv) 2013-03-19
WO2011075035A1 (en) 2011-06-23
RU2012124261A (ru) 2014-01-27
JP2013513659A (ja) 2013-04-22
SE0901565A1 (sv) 2011-06-16
AU2010332327A2 (en) 2012-07-12
EP2512510A4 (de) 2014-02-26
CN102791290A (zh) 2012-11-21
US20130122028A1 (en) 2013-05-16
EP2512510A1 (de) 2012-10-24
AU2010332327A1 (en) 2012-07-05
CA2783969A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
PH12020500308A1 (en) Preparation of therapeautic exosomes using membrane proteins
MY159398A (en) Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
CY1120471T1 (el) Αντισωματα κατα του cd70
MX2012001194A (es) Peptidos tau antigenicos y usos de los mismos.
MX346923B (es) Genes y proteinas para sintesis de alcanoil-coa.
MX2011010955A (es) Terapia complementaria contra el cancer.
MX2016005866A (es) Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales.
EA202091233A2 (ru) Новые способы иммунотерапии нескольких видов опухолей, в том числе рака желудочно-кишечного тракта и рака желудка
CY1107973T1 (el) Σχετιζομενα με ογκους πεπτιδια, που συνδεονται ετεροκλητως με μορια κλασεως ιι αντιγονου ανθρωπινων λευκοκυτταρων
NZ595939A (en) Use of modified peptide gamma-glu-abu for imparting or enhancing food or beverage taste
EA201171060A1 (ru) Молекулы антител, обладающих специфичностью к человеческому ох40
WO2011073215A3 (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
MX2011010977A (es) Composiciones inmunoterapeuticas combinadas contra cancer y metodos.
EA201071297A1 (ru) Новые и действенные пептиды мнс ii класса, полученные из сурвивина
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
WO2012079878A3 (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
AR128395A2 (es) Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9
MX2012011668A (es) Peptidos cdca5 y vacunas que incluyen los mismos.
IN2012DN05163A (de)
MX2013001836A (es) Proteina de fusion de fc recombinante del quinto dominio tipo iii de fibronectina de ddc.
UY32975A (es) Derivados de aminopiridina
IN2012DN00879A (de)
ATE475670T1 (de) Konsensus-peptid
MX342000B (es) Peptidos ect2 y vacunas que los incluyen.
GB201018125D0 (en) Peptide